

OUR SUPPORT—LIKE OUR TREATMENT—
IS CENTERED AROUND YOU
OUR SUPPORT—LIKE OUR TREATMENT—
IS CENTERED AROUND YOU
Home > Support & Resources > Enroll in Support Program
At each point in your treatment journey—from collection to creation to infusion and even after—there are support services available.
If you are receiving Bristol Myers Squibb CAR T cell therapy and you choose to enroll in the Cell Therapy 360® patient support program, you will be assigned a personal Patient Support Navigator to provide customized solutions and support throughout your treatment journey.
Cell Therapy 360 may be able to support eligible* patients and a care partner with transportation, lodging, and meal assistance throughout the patient journey.
Contact the call line to learn more about enrollment and Cell Therapy 360 support: (888) 805-4555
*Eligibility requirements apply.
Through the Copay Assistance Program, Cell Therapy 360 can cover out-of-pocket expenses for commercially insured patients for the Bristol Myers Squibb CAR T cell therapy product.†
The program is not available for patients who are enrolled in Medicare, Medicaid, TRICARE, the Veterans Affairs (VA), or any other federal or state healthcare program. The program will cover the out-of-pocket expenses of the Bristol Myers Squibb product only. Limitations apply. It does not cover the costs of any other healthcare provider charges or any other treatment costs. Patients are responsible for non-drug-related out-of-pocket costs. Additional eligibility requirements may apply. Bristol Myers Squibb reserves the right to rescind, revoke, or amend this program without notice.
†Additional assistance may be available for patients with commercial insurance with no out-of-pocket maximum. Additional eligibility requirements may apply.